Lyell Immunopharma, Inc. - Common Stock - Nakit Akışı (NASDAQ:LYEL) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -126.25 M-169.56 M-163.69 M-162.39 M-150.02 M -133.8 M Yatırım faaliyetlerinden elde edilen nakit -121.57 M-11.54 M184.05 M122.42 M54.1 M 2.01 M Finansman faaliyetlerinden elde edilen nakit 401.24 M10.63 M1.74 M1.33 M50.41 M 102.13 M Serbest nakit akışı -126.25 M-169.56 M-163.69 M-162.39 M-150.8 M -134.42 M

Haberler

Lyell Immunopharma, Inc. (LYEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript

Down 33.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Lyell Immunopharma (LYEL)

Baird, Lyell Immunopharma hissesi için alım tavsiyesi verdi

BofA, Lyell Immunopharma hissesi için Düşük Performans görüşünü yineledi

Lyell Immunopharma, Inc. (LYEL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

A First Look At Lyell Immunopharma (NASDAQ:LYEL)

Lyell Immunopharma Stock (LYEL) Slides Despite Praise from a Top Wall Street Analyst - TipRanks.com

Morning News Wrap-Up 4/10/26: Today’s Biggest Stock Market Stories! - TipRanks.com

Lyell Immunopharma: Strong Early CAR-T Data, And Now A More Measured Bet (NASDAQ:LYEL)

H.C. Wainwright, Lyell Immunopharma hissesi için al önerisini korudu

Citizens, Lyell Immunopharma hissesi için tavsiyesini korudu

Citizens reiterates Lyell Immunopharma stock rating on trial progress